What is it?
A root preparation with several names
6He Shou Wu and Fo-Ti refer here to preparations of the root known as Polygonum multiflorum. Fallopia multiflora and Reynoutria multiflora also appear on labels and in regulator notices. A botanical name identifies the plant, but does not specify whether the root is raw, traditionally processed, or extracted.
What the cognitive research actually shows
2The 2024 cognitive review summarizes animal and other experimental models, including maze tests and cellular pathways. Those results do not demonstrate better human memory, focus or daily function. Hair-color and longevity traditions are also not a substitute for controlled clinical outcomes.
Names, aliases and forms
Mechanisms of action
Laboratory pathways are not proven benefits
2Stilbene compounds and emodin, an anthraquinone constituent, have been studied in models of oxidative stress and neurodegeneration. Such experiments can generate hypotheses, but neither an isolated constituent nor an animal extract dose predicts the effects of a commercial root product in a person.
Potential effects and evidence map
Grade D reflects mainly preclinical cognitive research. A 2024 review concerns experimental models, not demonstrated memory or focus benefits in healthy people. Traditional use and laboratory mechanisms do not establish a clinical nootropic effect.
Cognitive-model findings remain preclinical; a meaningful human benefit is not established.
Timing & effect horizon
The reviewed sources do not establish an effective and acceptably safe cognitive-use dose. Traditional gram quantities, capsule milligrams and concentrated extract weights refer to different preparations. A historical dose or a seller's serving size is not a demonstrated safety threshold; more is not evidence of greater benefit.
There is no supported whole-root human The time for blood levels to fall by half during the final elimination phase.Source, cognitive onset, useful effect duration or cycle schedule in the reviewed evidence. Liver injury has been reported after both brief and longer exposure. Symptom-free days do not establish a safe course, and injury latency should not be read as a benefit timeline.
Safety, side effects and risk profile
Rare liver injury can require hospitalization and has sometimes led to liver failure.
A review assembled 450 liver-injury cases involving raw root, processed root and compound products. Most improved after stopping, but transplantation and deaths occurred. These are selected injury reports, not 450 representative users: the outcomes cannot be converted into your personal probability of harm or used to rank products by safety.
In one Korean hospital series, 25 adults had hepatitis after oral root preparations, mainly tea. Twenty-three recovered, one required transplantation and one died. Products and patient histories varied, and this hospital sample cannot estimate incidence; it does show why a simple tea or powder is not automatically harmless.
The cited efficacy literature does not establish a useful or safe nootropic regimen for pregnancy, breastfeeding or children. Do not extrapolate adult traditional use to those groups; a qualified clinician should assess any proposed use.
Interactions and cautions
Human interaction evidence is limited, so a compatibility checklist cannot establish a safe stack. Share all medicines, supplements and alcohol use with a clinician, particularly when liver health is already a concern. No evidence here supports a spacing rule, cycling protocol or companion supplement as reliable protection against Fo-Ti liver injury.
Legal and regulatory status
Checked 2026-10-12: the TGA's 2019 advisory describes rare liver harm and recalls of Fusion Hair Tonic and Oriental Botanicals Hairpro. It also described liver-warning requirements for oral listed medicines. That historical action does not mean every Fo-Ti product is banned, currently authorized, or safe, and it does not determine rules outside Australia.
As of 2026-10-12, Australia's listed-medicine framework requires ingredients to appear in the applicable permissible-ingredients determination and comply with its restrictions and labeling conditions. Verify the current determination and the particular product: an old advisory or overseas shop listing is not authorization. Other markets need their own current checks.
How it compares
Traditional processing changes the preparation and its chemical composition; it often involves black-bean liquid. Liver injury has been reported with both raw and processed forms. A processed or prepared label describes manufacture, not proof that the finished product is non-hepatotoxic.
Practical buying and quality notes
- First match the botanical ingredient, root preparation, single-herb versus blend status and extract specification. Only then compare price per gram of that same material or per identically specified serving. A larger extract ratio does not demonstrate greater clinical benefit, and root-equivalent weight is not the same measurement as extract weight.5
- A clear ingredient list and batch-specific identity and contaminant testing can help assess product quality. They do not remove the intrinsic liver-injury concern seen in the clinical literature. Neither a clean certificate nor a low price makes an oral Fo-Ti product proven safe.4
FAQ
What Fo-Ti dosage is supported for memory?
2No validated human memory-enhancement dose emerges from the reviewed evidence. The preclinical literature does not justify converting an animal dose into a capsule recommendation.
How long should a He Shou Wu cycle last?
4A safe or effective nootropic cycle has not been established. Case reports cover short and prolonged exposures, so a brief cycle or scheduled break cannot be presented as liver protection.
Is processed Fo-Ti safe to buy?
3Processing does not eliminate the documented liver-injury signal. Compare forms to understand what a label contains, not to assume one form is a proven safe choice.
References
- NIDDK LiverTox. Polygonum Multiflorum. Updated August 2020.
- Preclinical Evidence and Underlying Mechanisms of Polygonum multiflorum and Its Chemical Constituents Against Cognitive Impairments and Alzheimer's Disease. 2024.
- Lei et al. Liver Damage Associated with Polygonum multiflorum: Systematic Review of Case Reports and Case Series. 2015.
- Jung et al. Twenty Five Cases of Acute Hepatitis Following Ingestion of Polygonum multiflorum. Gut and Liver. 2011.
- Liu et al. Polygonum multiflorum-Induced Liver Injury: Clinical Characteristics, Risk Factors and Current Challenges. 2019.
- TGA. Fallopia multiflora (he shou wu): safety advisory and product recalls. 2019.
- TGA. Permissible ingredients determination: listed-medicine requirements.